IndiaA controversy arose after comedian Rahul Dua claimed that immunotherapy is 'better' than chemotherapy, prompting backlash from oncologists who emphasized that cancer treatment decisions depend on factors like tumor type, biomarkers, side effects, and accessibility. Experts argue that neither therapy is universally superior and that the choice often involves combining both approaches depending on the specific case. Globally, cancer remains a significant public health issue, with rising numbers of new cases and deaths expected in the coming years. In India, the country faces a growing cancer burden, with millions of new cases reported annually. While immunotherapy represents a major advancement in cancer care, particularly through immune checkpoint inhibitors, chemotherapy continues to play a vital role in treating various types of cancer.
Bias read (Center): The article discusses medical treatments and their effectiveness in cancer care, focusing on expert opinions rather than taking a stance on political issues. The content is balanced, presenting views from oncologists without apparent bias toward either immunotherapy or chemotherapy.
